Ampio Pharmaceuticals Details Early Positive Results for Inhaled Ampion in COVID-19 Respiratory Distress prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
ENGLEWOOD, Colo., March 3, 2021 /PRNewswire/ Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today reported annual financial results for the year ended December 31, 2020 and provided a corporate overview / business update.
Mr. Michael Macaluso, President and CEO, noted, The FDA has recently responded to our requests to expand our IV and Inhalation Covid-19 studies, utilizing Ampion, by recommending we conduct a randomized, double-blinded, placebo-controlled Phase II trial in each. They also indicated that their recommended trial design for both will allow for an effective and efficient review of data results, determine the safety and statistical significance and effectiveness of Ampion in comparison to Standard of Care, all of which are necessary for the FDA to objectively determine that the known and potential benefit
These 3 Penny Stocks Were Trending On December 31st; Can That Continue?
As New Yearâs Eve comes and goes, a new year for penny stocks is upon us. In 2021, there are several factors that could change the trajectory of certain stocks. As investors, we always have to think critically and be ahead of the game. This means finding the most current events and utilizing them to pick a strategy. When putting your list of penny stocks together, investors should first consider their timeline. While day traders like to be in and out of positions quickly, other types of traders may want to hold longer. The first of those is known as a swing trader.